Home > Products > CD19 & CD47 > Recombinant Human Anti-CD19 x Human Anti-CD47 Bispecific Antibody (scIgG)

Recombinant Human Anti-CD19 x Human Anti-CD47 Bispecific Antibody (scIgG)  (CAT#: SCIGG-H219)

Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD19 and anti-CD47 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget macrophages to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia therapy.
Datasheet INQUIRY

Specifications

Targets
CD19 & CD47
Type
Single chain IgGs
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia

Targets

Target 1
CD19
Gene ID
UniProt ID
Alternative Names
CD19; CD19 molecule; Cluster of differentiation 19; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4
Target 2
CD47
Gene ID
UniProt ID
Alternative Names
CD47; CD47 molecule; IAP; OA3; MER6; leukocyte surface antigen CD47; CD47 glycoprotein; Rh-related antigen; integrin associated protein; integrin-associated protein; integrin-associated signal transducer; antigenic surface determinant protein OA3; antigen identified by monoclonal antibody 1D8; CD47 antigen (Rh-related antigen, integrin-associated signal transducer)
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD19 & CD47"
See other bsAb targets related to "CD19"

See other bsAb targets related to "CD47"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD19 x Human Anti-CD47 Bispecific Antibody (scIgG) (SCIGG-H219). Click the button below to contact us or submit your feedback about this product.